2012
DOI: 10.1152/ajpheart.00477.2012
|View full text |Cite
|
Sign up to set email alerts
|

Effects of neuronal nitric oxide synthase inhibition on microvascular and contractile function in skeletal muscle of aged rats

Abstract: Hirai DM, Copp SW, Holdsworth CT, Ferguson SK, Musch TI, Poole DC. Effects of neuronal nitric oxide synthase inhibition on microvascular and contractile function in skeletal muscle of aged rats. Am J Physiol Heart Circ Physiol 303: H1076 -H1084, 2012. First published August 24, 2012; doi:10.1152 doi:10. /ajpheart.00477.2012 age is associated with derangements in skeletal muscle microvascular function during the transition from rest to contractions. We tested the hypothesis that, contrary to what was reported p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
10
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 8 publications
(11 citation statements)
references
References 65 publications
1
10
0
Order By: Relevance
“…First, SMTC is a potent nNOS inhibitor which possesses a 17-fold selectivity for nNOS over eNOS in rat tissue in vivo (Furfine et al, 1994) and induced significant increases in MAP herein. Second, 0.56 mg/kg of SMTC (the identical dose utilized herein) does not attenuate the hypotensive response to rapid acetylcholine (ACh) infusion whereas it is blunted (smaller Δ MAP and faster recovery time) following non-selective NOS inhibition with L-NAME (Copp et al, 2010, 2011, 2012; Hirai et al, 2012). This is a crucial observation given that vasodilation in response to ACh is due, in large part, to eNOS-derived NO.…”
Section: Discussionmentioning
confidence: 96%
See 2 more Smart Citations
“…First, SMTC is a potent nNOS inhibitor which possesses a 17-fold selectivity for nNOS over eNOS in rat tissue in vivo (Furfine et al, 1994) and induced significant increases in MAP herein. Second, 0.56 mg/kg of SMTC (the identical dose utilized herein) does not attenuate the hypotensive response to rapid acetylcholine (ACh) infusion whereas it is blunted (smaller Δ MAP and faster recovery time) following non-selective NOS inhibition with L-NAME (Copp et al, 2010, 2011, 2012; Hirai et al, 2012). This is a crucial observation given that vasodilation in response to ACh is due, in large part, to eNOS-derived NO.…”
Section: Discussionmentioning
confidence: 96%
“…This is consistent with transient SMTC-induced MAP elevations reported previously (Komers et al, 2000; Wakefield et al, 2003). Importantly, in recent investigations from our laboratory MAP, HR, and skeletal muscle and kidney blood flow were measured ~4–5 minutes following SMTC administration (Copp et al, 2010, 2011, 2012; Hirai et al, 2012). Thus, the present data support that those measurements occurred when the cardiovascular effects of SMTC were peaking.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Beside endothelial eNOS activity or NO metabolism, limitations of NO-availability may possibly also arise neuronal NOS as another NO sources, that shows an age-related impact on microcirculation [61]. Furthermore, aging may lead to a NO-dependent redistribution of microvascular blood flow distribution from ‘red’ and ‘white’ muscle groups/ regions with consequences for endurance training effects [8, 62, 63].…”
Section: Discussionmentioning
confidence: 99%
“…2001; Copp et al . 2012) and aged (Hirai et al . 2012) populations which have been associated with impaired nNOS‐mediated function.…”
Section: Introductionmentioning
confidence: 99%